NDC 63323-140

Cladribine

Cladribine

Cladribine is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Fresenius Kabi Usa, Llc. The primary component is Cladribine.

Product ID63323-140_9b00e23f-d8e3-87f7-e053-2995a90a038f
NDC63323-140
Product TypeHuman Prescription Drug
Proprietary NameCladribine
Generic NameCladribine
Dosage FormInjection
Route of AdministrationINTRAVENOUS
Marketing Start Date2004-12-01
Marketing CategoryANDA / ANDA
Application NumberANDA076571
Labeler NameFresenius Kabi USA, LLC
Substance NameCLADRIBINE
Active Ingredient Strength1 mg/mL
Pharm ClassesPurine Antimetabolite [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 63323-140-10

1 VIAL, SINGLE-DOSE in 1 CARTON (63323-140-10) > 10 mL in 1 VIAL, SINGLE-DOSE
Marketing Start Date2004-12-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 63323-140-10 [63323014010]

Cladribine INJECTION
Marketing CategoryANDA
Application NumberANDA076571
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2004-12-01

Drug Details

Active Ingredients

IngredientStrength
CLADRIBINE1 mg/mL

OpenFDA Data

SPL SET ID:a2592a9b-bca6-4a5a-89c2-855a0634d5fe
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 240754
  • UPC Code
  • 0363323140106
  • Pharmacological Class

    • Purine Antimetabolite [EPC]

    NDC Crossover Matching brand name "Cladribine" or generic name "Cladribine"

    NDCBrand NameGeneric Name
    0143-9871CladribineCladribine
    42658-010CladribineCladribine
    63323-140CladribineCLADRIBINE
    67457-450CladribineCladribine
    44087-4000MavencladCladribine

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.